Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May;27(5):229-232.
doi: 10.1016/j.jccase.2023.01.004. Epub 2023 Jan 27.

Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report

Naoaki Onishi  1 , Yuki Konishi  2 , Toshiyuki Kaneko  2 , Naohiro Maekawa  2   3 , Akihira Suenaga  1 , Shinnosuke Nomura  1   3 , Takayasu Kobayashi  1 , Shokan Kyo  1 , Marie Okabayashi  1 , Hirooki Higami  1 , Maki Oi  1 , Nobuya Higashitani  1 , Sayaka Saijo  1 , Fumiko Nakazeki  1 , Naofumi Oyamada  1 , Toshikazu Jinnai  1 , Tomoko Okuno  4 , Tomoyuki Shirase  4 , Kazuaki Kaitani  1
Affiliations
Case Reports

Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report

Naoaki Onishi et al. J Cardiol Cases. 2023 May.

Abstract

A 71-year-old man was transferred urgently to our hospital after collapsing near his home post the first shot of the BNT162b2 coronavirus disease 2019 vaccine (Pfizer-BioNTech, Comirnaty®). Immediately after arrival at our hospital, cardiac arrest due to complete atrioventricular block with no ventricular escaped beats was observed on electrocardiogram. Echocardiography showed preserved left ventricular ejection fraction, however, diffuse severe hypokinesia was revealed after 3 weeks, and he died 3 months after admission because of worsening heart failure. An autopsy examination revealed eosinophilic myocarditis or hypersensitivity myocarditis with extensive fibrosis and widespread myocardial dropout throughout the heart.

Learning objective: 1. Severe myocarditis occurs extremely rarely after mRNA coronavirus disease 2019 (COVID-19) vaccination. 2. Myocarditis after mRNA COVID-19 vaccination might cause complete atrioventricular block, followed by a course of decreased left ventricular ejection fraction. 3. Histologically, severe myocarditis after mRNA COVID-19 vaccination seems to present as fulminant necrotizing eosinophilic myocarditis or hypersensitivity myocarditis.

Keywords: BNT162b2; Complete atrioventricular block; Coronavirus disease 2019; Eosinophilic myocarditis; Hypersensitivity myocarditis; mRNA.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
12-lead electrocardiogram (ECG). (a) Complete atrioventricular block with no ventricular escaped beats observed immediately after arrival at our hospital, (b) ECG after resumption of own heartbeat after adrenaline administration, (c) ECG 9 months before admission by the patient's family doctor, (d) sinus tachycardia after hospitalization.
Fig. 2
Fig. 2
Endomyocardial biopsy. Hematoxylin–eosin stains of heart tissue specimens obtained via left ventricular endomyocardial biopsy on the 27th day of admission. Images of the hematoxylin–eosin stains were obtained using 100× and 600× objectives. Arrows indicate eosinophils.
Fig. 3
Fig. 3
Autopsy findings of the ventricular septum. (a) Macroscopic view of the ventricular septal region and Masson trichrome stained images (10×) and (b) strongly magnified image (600×) with hematoxylin–eosin staining. The arrow in (b) indicates eosinophils. (c) The atrioventricular (AV) node is indicated using hematoxylin–eosin staining (600×). LV, left ventricle; RV, right ventricle.
See this image and copyright information in PMC

References

    1. Lamb Y.N. BNT162b2 mRNA COVID-19 vaccine: first approval. Drugs. 2021;81:495–501. - PMC - PubMed
    1. Oster M.E., Shay D.K., Su J.R., Gee J., Creech C.B., Broder K.R., Edwards K., Soslow J.H., Dendy J.M., Schlaudecker E., Lang S.M., Barnett E.D., Ruberg F.L., Smith M.J., Campbell M.J., et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327:331–340. - PMC - PubMed
    1. Haddadin F.I., Mahdawi T.E., Hattar L., Beydoun H., Fram F., Homoud M. A case of complete heart block in a COVID-19 infected patient. J Cardiol Cases. 2021;23:27–30. - PMC - PubMed
    1. Shams P., Ali J., Saadia S., Khan A.H., Sultan F.A.T., Tai J. COVID-19 BBIBP-CorV vaccine and transient heart block – a phenomenon by chance or a possible correlation – a case report. Ann Med Surg. 2021;71 - PMC - PubMed
    1. Ameratunga R., Woon S.T., Sheppard M.N., Garland J., Ondruschka B., Wong C.X., Stewart R.A.H., Tatley M., Stables S.R., Tse R.D. First identified case of fatal fulminant eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2, Comirnaty): an extremely rare idiosyncratic hypersensitivity reaction. J Clin Immunol. 2022;42:441–447. - PMC - PubMed

Publication types

LinkOut - more resources